Literature DB >> 11900816

Effects of progesterone treatment on smoked cocaine response in women.

Mehmet Sofuoglu1, David A Babb, Dorothy K Hatsukami.   

Abstract

The effects of female sex hormones on responses to cocaine have not been systematically investigated in women. In this study, the safety and efficacy of acute progesterone treatment on smoked cocaine response was examined in female cocaine users. Five women had two experimental sessions during the early follicular phase, within 3-9 days after the beginning of their menses. In each experimental session, subjects received a single 200-mg dose of progesterone or placebo orally. Starting 2 h after the medication treatment, subjects received three deliveries of 0.4-mg/kg smoked cocaine 30 min apart. Progesterone treatment, compared to placebo, did not affect the blood pressure and heart rate changes in response to cocaine deliveries. For subjective responses to cocaine, the average of five-item Cocaine Effects Questionnaire (CEQ) was attenuated under progesterone treatment compared to placebo. For individual items of CEQ, progesterone treatment was associated with diminished rating of "feel the effect of last dose" in response to cocaine. These preliminary results suggest that acute progesterone treatment, given during the early follicular phase, may attenuate some of the subjective effects of cocaine. Further studies are warranted to examine the effects of progesterone treatment on cocaine dependence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900816     DOI: 10.1016/s0091-3057(02)00716-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  65 in total

1.  How reward and emotional stimuli induce different reactions across the menstrual cycle.

Authors:  Michiko Sakaki; Mara Mather
Journal:  Soc Personal Psychol Compass       Date:  2012-01-01

Review 2.  Role of progesterone in nicotine addiction: evidence from initiation to relapse.

Authors:  Wendy J Lynch; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

3.  Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progestogen levels among intact rats.

Authors:  Amy S Kohtz; Jason J Paris; Cheryl A Frye
Journal:  Horm Behav       Date:  2010-02-19       Impact factor: 3.587

Review 4.  Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-09-18       Impact factor: 3.533

5.  Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques.

Authors:  Ziva D Cooper; Richard W Foltin; Suzette M Evans
Journal:  Horm Behav       Date:  2012-10-23       Impact factor: 3.587

6.  Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Drug Alcohol Depend       Date:  2009-12-14       Impact factor: 4.492

7.  Sex-dependent effects of cannabis-induced analgesia.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Drug Alcohol Depend       Date:  2016-08-05       Impact factor: 4.492

Review 8.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

Review 9.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

10.  Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats.

Authors:  Justin J Anker; Nathan A Holtz; Natalie Zlebnik; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2008-11-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.